Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Chubb
Boehringer Ingelheim
Citi
Queensland Health
Julphar
Daiichi Sankyo
UBS

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090221

« Back to Dashboard

NDA 090221 describes ALFUZOSIN HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan, Sun Pharma Global, Teva Pharms, Torrent Pharms, Unichem Labs Ltd, and Wockhardt Ltd, and is included in nine NDAs. It is available from nineteen suppliers. Additional details are available on the ALFUZOSIN HYDROCHLORIDE profile page.

The generic ingredient in ALFUZOSIN HYDROCHLORIDE is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.
Summary for 090221
Tradename:ALFUZOSIN HYDROCHLORIDE
Applicant:Wockhardt Ltd
Ingredient:alfuzosin hydrochloride
Patents:0
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 090221
Mechanism of ActionAdrenergic alpha-Antagonists
Suppliers and Packaging for NDA: 090221
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 090221 ANDA Wockhardt Limited 55648-738 N 55648-738-01
ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 090221 ANDA Wockhardt Limited 55648-738 N 55648-738-02

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Aug 10, 2012TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
Fuji
Moodys
Daiichi Sankyo
QuintilesIMS
UBS
Teva
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.